Arcturus Therapeutics Holdings (ARCT) Other Non-Current Liabilities (2021 - 2023)

Arcturus Therapeutics Holdings (ARCT) has 3 years of Other Non-Current Liabilities data on file, last reported at $497000.0 in Q4 2023.

• Quarterly Other Non-Current Liabilities fell 82.28% year-over-year to $497000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $497000.0 (down 82.28% YoY) and the FY2023 annual result came in at $497000.0, down 82.28% from the prior year.
• Other Non-Current Liabilities fell to $497000.0 in Q4 2023, from $976000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $3.7 million in Q3 2022 to a low of $358000.0 in Q1 2021.
• A 3-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 163.7% — and 2023, when it sank 82.28%.
• Tracing ARCT's Other Non-Current Liabilities over 3 years: stood at $1.4 million in 2021, then surged by 101.15% to $2.8 million in 2022, then slumped by 82.28% to $497000.0 in 2023.
• The last three Other Non-Current Liabilities figures came in at $497000.0 (Q4 2023), $976000.0 (Q3 2023), and $1.3 million (Q2 2023), per Business Quant data.